Cancer-Killing Viruses Enter in Stealth Mode, Penetrate Immune Barrier

Viruses that, when administered to patients, preferentially attack and kill cancer cells, leaving normal tissues unscathed. It might sound like science fiction, but oncolytic viruses are, in fact, already a (small) part of oncologists’ toolkit. Five years ago, the U.S. FDA approved the first and only oncolytic virus therapy called talimogene laherparepvec (T-VEC, or…

--

--

--

Follow me for bite-sized stories on the latest discoveries and innovations in biomedical research.

Love podcasts or audiobooks? Learn on the go with our new app.

Recommended from Medium

Laser Beams Vibrate Viruses to Distinguish Them

WHO creates global platform to share information on vaccine research

A Blood Test for Predicting if You’ll Live to 100

Cancer-Sniffing Worms: The Future of Diagnostics?

From Quantum to Energy, from Energy to Information

Molecular Scientists Have Discovered A Way To Make “Computers” From Liquid Crystals

Norman Borlaug, the Man Who Saved the World from Starvation

Nanoengineering Aids Bladder Cancer Detection

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
River D'Almeida, Ph.D

River D'Almeida, Ph.D

Follow me for bite-sized stories on the latest discoveries and innovations in biomedical research.

More from Medium

AI Platform Finds Superbugs Faster

The Genetics of Type 2 Diabetes: Different Genes, Different Subtypes?

Scientists Win a Game of Bacterial Hide-And-Seek

Violet Extract Boosts Brain Cancer Drug’s Performance